<DOC>
	<DOCNO>NCT00479375</DOCNO>
	<brief_summary>Human papillomavirus ( HPV ) -based cervical screening know increase sensitivity detection high-grade cervical intraepithelial neoplasia ( CIN ) . Randomized trial longitudinal efficacy require ass whether gain represent overdiagnosis protective effect . Methods : A total 12527 woman , age 32-38 , attend population-based invitational screening Sweden randomize 1:1 HPV test cytology ( intervention arm ) cytology ( control arm ) . HPV-positive woman invite second HPV test least one year later woman type-specific persistent infection invite colposcopy . A similar number random double-blinded procedure perform control arm . Women follow comprehensive registry-based follow-up . Primary outcome relative rate CIN grade 2 worse ( CIN2/CIN3+ ) find subsequent screening . Secondary outcomes relative rate CIN2/CIN3+ find aseline screen outcome stratify grade CIN ( CIN 2 CIN3+ ) .</brief_summary>
	<brief_title>Randomized Controlled Trial Human Papillomavirus Testing Primary Cervical Cancer Screening</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<criteria>Women age 3238 year old Attending Swedish populationbased organised cervical screen program Not provide inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>32 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>screen</keyword>
	<keyword>human papillomavirus</keyword>
</DOC>